Photosensitivity associated with selective serotonin reuptake inhibitors.

Abstract

Selective serotonin reuptake inhibitors (SSRIs) are a widely prescribed group of antidepressants. We report three cases of photosensitivity induced by fluvoxamine and paroxetine. These photoallergic reactions suggest cross-reactivity between different molecules. Methylation metabolism could explain common photosensitization. Although these drugs are widely prescribed, such photosensitization is rare. Nevertheless, we consider that clinicians and patients should be aware of the risk of photosensitization and these drugs should be stopped before phototherapy or prolonged sun exposure.

• Authors: V Doffoel-Hantz, C Boulitrop-Morvan, A Sparsa, J M Bonnetblanc, S Dalac, C Bédane
• Journal: Clinical and experimental dermatology (Clin Exp Dermatol) Vol. 34 Issue 8 Pg. e763-5 (Dec 2009) ISSN: 1365-2230 [Electronic] England
• PMID: 19817765 (Publication Type: Case Reports, Journal Article)

Chemical References

• Antidepressive Agents
• Serotonin 5-HT2 Receptor Antagonists
• Serotonin Uptake Inhibitors
• Fluvoxamine

Topics

• Aged
• Antidepressive Agents (adverse effects)
• Drug Eruptions (etiology)
• Female
• Fluvoxamine (adverse effects)
• Humans
• Male
• Middle Aged
• Photosensitivity Disorders (chemically induced)
• Serotonin 5-HT2 Receptor Antagonists
• Selective Serotonin Reuptake Inhibitors (adverse effects)